Tang Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,500,000
| Closed | -$13M | – | 193 |
|
2024
Q3 | $13M | Buy |
2,500,000
+2,100,000
| +525% | +$10.9M | 0.93% | 34 |
|
2024
Q2 | $1.03M | Buy |
400,000
+200,000
| +100% | +$514K | 0.1% | 93 |
|
2024
Q1 | $984K | Buy |
+200,000
| New | +$984K | 0.1% | 88 |
|
2022
Q4 | – | Sell |
-287,500
| Closed | -$7.76M | – | 107 |
|
2022
Q3 | $7.76M | Buy |
+287,500
| New | +$7.76M | 0.95% | 32 |
|